Phosphatase and tensin homolog

Phosphatase and tensin homolog (PTEN) is a protein that in humans is encoded by the PTEN gene. PTEN is a tumor suppressor gene that is involved in the regulation of the cell cycle, preventing cells from growing and dividing too rapidly or in an uncontrolled way.

Structure

PTEN is a dual-specificity phosphatase that is capable of dephosphorylating both protein and lipid substrates. The protein consists of several domains:

• The N-terminal phosphatase domain, which is responsible for its enzymatic activity.
• The C2 domain, which helps in binding to cell membranes.
• The C-terminal tail, which contains several phosphorylation sites that regulate PTEN's stability and activity.

Function

PTEN functions primarily as a lipid phosphatase, dephosphorylating the 3' phosphate of the inositol ring of phosphatidylinositol (3,4,5)-trisphosphate (PIP3), converting it to phosphatidylinositol (4,5)-bisphosphate (PIP2). This action antagonizes the PI3K/AKT/mTOR pathway, which is a critical signaling pathway for cell growth and survival.

Role in Cell Cycle Regulation

By reducing PIP3 levels, PTEN negatively regulates the AKT signaling pathway, leading to decreased cell proliferation and increased apoptosis. This makes PTEN a crucial player in maintaining normal cell cycle progression and preventing tumorigenesis.

Role in Development

PTEN is also involved in embryonic development, where it regulates cell migration and angiogenesis. Its role in maintaining stem cell populations and differentiation is also significant.

Clinical Significance

Mutations in the PTEN gene are associated with several cancers, including breast cancer, prostate cancer, and glioblastoma. PTEN mutations can lead to uncontrolled cell proliferation due to the loss of its tumor suppressor function.

PTEN Hamartoma Tumor Syndrome

PTEN mutations are also linked to a group of disorders known as PTEN hamartoma tumor syndrome (PHTS), which includes conditions such as Cowden syndrome, Bannayan-Riley-Ruvalcaba syndrome, and Proteus syndrome. These syndromes are characterized by the development of multiple benign tumors and an increased risk of malignancies.

Research and Therapeutic Implications

Research into PTEN has significant implications for cancer therapy. Restoring PTEN function or mimicking its activity could be a potential strategy for treating cancers with PTEN loss. Additionally, understanding PTEN's role in other diseases could lead to novel therapeutic approaches.

See Also

• Tumor suppressor gene
• PI3K/AKT/mTOR pathway
• Cell cycle
• Apoptosis

External Links

• PTEN Gene - NCBI
• PTEN Protein - UniProt

This article is a stub related to proteins. You can help WikiMD by expanding it!